| Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody JS McLellan, M Chen, S Leung, KW Graepel, X Du, Y Yang, T Zhou, ... Science 340 (6136), 1113-1117, 2013 | 822 | 2013 |
| Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys P Abbink, RA Larocca, RA De La Barrera, CA Bricault, ET Moseley, ... Science 353 (6304), 1129-1132, 2016 | 550 | 2016 |
| Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera JO Ngwuta, M Chen, K Modjarrad, MG Joyce, M Kanekiyo, A Kumar, ... Science translational medicine 7 (309), 309ra162-309ra162, 2015 | 363 | 2015 |
| Evaluation of candidate vaccine approaches for MERS-CoV L Wang, W Shi, MG Joyce, K Modjarrad, Y Zhang, K Leung, CR Lees, ... Nature communications 6 (1), 7712, 2015 | 318 | 2015 |
| Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial K Modjarrad, CC Roberts, KT Mills, AR Castellano, K Paolino, ... The Lancet Infectious Diseases 19 (9), 1013-1022, 2019 | 317 | 2019 |
| Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol Y Arabi, H Balkhy, AH Hajeer, A Bouchama, FG Hayden, A Al-Omari, ... Springerplus 4, 1-8, 2015 | 250 | 2015 |
| A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants B Dearlove, E Lewitus, H Bai, Y Li, DB Reeves, MG Joyce, PT Scott, ... Proceedings of the National Academy of Sciences 117 (38), 23652-23662, 2020 | 241 | 2020 |
| Effect of treating co-infections on HIV-1 viral load: a systematic review K Modjarrad, SH Vermund The Lancet infectious diseases 10 (7), 455-463, 2010 | 241 | 2010 |
| WHO consultation on respiratory syncytial virus vaccine development report from a World Health Organization meeting held on 23–24 March 2015 K Modjarrad, B Giersing, DC Kaslow, PG Smith, VS Moorthy, ... Vaccine 34 (2), 190-197, 2016 | 212 | 2016 |
| Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo … K Modjarrad, L Lin, SL George, KE Stephenson, KH Eckels, ... The Lancet 391 (10120), 563-571, 2018 | 201 | 2018 |
| Status of vaccine research and development of vaccines for Staphylococcus aureus BK Giersing, SS Dastgheyb, K Modjarrad, V Moorthy Vaccine 34 (26), 2962-2966, 2016 | 179 | 2016 |
| Importance of neutralizing monoclonal antibodies targeting multiple antigenic sites on the Middle East respiratory syndrome coronavirus spike glycoprotein to avoid … L Wang, W Shi, JD Chappell, MG Joyce, Y Zhang, M Kanekiyo, ... Journal of virology 92 (10), 10.1128/jvi. 02002-17, 2018 | 170 | 2018 |
| Developing global norms for sharing data and results during public health emergencies K Modjarrad, VS Moorthy, P Millett, PS Gsell, C Roth, MP Kieny PLoS Medicine 13 (1), e1001935, 2016 | 154 | 2016 |
| Impact of prior flavivirus immunity on Zika virus infection in rhesus macaques MK McCracken, GD Gromowski, HL Friberg, X Lin, P Abbink, ... PLoS pathogens 13 (8), e1006487, 2017 | 152 | 2017 |
| Novel antigens for RSV vaccines BS Graham, K Modjarrad, JS McLellan Current opinion in immunology 35, 30-38, 2015 | 151 | 2015 |
| Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression K Modjarrad, E Chamot, SH Vermund Aids 22 (16), 2179-2185, 2008 | 143 | 2008 |
| Deployable CRISPR-Cas13a diagnostic tools to detect and report Ebola and Lassa virus cases in real-time KG Barnes, AE Lachenauer, A Nitido, S Siddiqui, R Gross, B Beitzel, ... Nature communications 11 (1), 4131, 2020 | 127 | 2020 |
| SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity MG Joyce, WH Chen, RS Sankhala, A Hajduczki, PV Thomas, M Choe, ... Cell reports 37 (12), 2021 | 123 | 2021 |
| Durability and correlates of vaccine protection against Zika virus in rhesus monkeys P Abbink, RA Larocca, K Visitsunthorn, M Boyd, RA De La Barrera, ... Science translational medicine 9 (420), eaao4163, 2017 | 123 | 2017 |
| A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates MG Joyce, HAD King, I Elakhal-Naouar, A Ahmed, KK Peachman, ... Science translational medicine 14 (632), eabi5735, 2021 | 93 | 2021 |
